The Senior Accountant will collaborate closely with members of the Accounting team to support internal reporting, external reporting, audit requests, SOX compliance, and process improvement initiatives. This position is a great opportunity for someone who is detail-oriented, organized, pro-active, and excited to gain exposure to a broad range of accounting areas within a growing public biotechnology company. The ideal candidate will be comfortable working in a fast-paced environment, able to manage multiple priorities, and willing to take initiative. This role requires strong Excel skills, clear communication, attention to detail, and a team-oriented approach.
Position Responsibilities
- Prepare month-end journal entries and account reconciliations/supporting schedules across cash, prepaid expenses, fixed assets, accruals, G&A activity, and other GL accounts
- Perform account analyses, investigate variances, and support timely, accurate completion of monthly/quarterly close activities
- Prepare schedules and documentation supporting internal reporting, external reporting, audits, quarterly reviews, and SOX compliance
- Partner with cross-functional teams to gather information needed for accounting entries and analysis
- Support efforts to continuously drive cross-functional improvements, as well as create process documentation
- Execute special ad-hoc projects as requested to support the greater Finance team
Candidate Requirements
- Bachelor’s degree in Accounting, Finance, or related field
- 3-5 years of relevant accounting experience
- CPA or equivalent is preferred
- Life sciences, biotechnology, or pharmaceutical industry experience preferred
- Public company experience preferred
- NetSuite and/or SAP experience preferred
- Experience with month-end close, journal entries, reconciliations, and account analysis
- Exposure to SOX controls and audit support preferred
- Strong organizational skills and ability to manage multiple priorities in a fast-paced environment
- Ability to work independently, take initiative, and follow through on open items
- Strong communication skills and ability to work effectively with team members and cross-functional partners
- Strong Excel and computer skills required
- Strong attention to detail and ability to produce accurate, well-supported work
- Curious, proactive, and motivated to learn and grow within a developing accounting organization
Skills Required
- Bachelor's degree in Accounting, Finance, or a related field
- 3-5 years of relevant accounting experience
- Experience with month-end close, journal entries, reconciliations, and account analysis
- Strong organizational skills and ability to manage multiple priorities in a fast-paced environment
- Ability to work independently, take initiative, and follow through on open items
- Strong communication skills and ability to work effectively with team members and cross-functional partners
- Strong Excel and computer skills
- Strong attention to detail and ability to produce accurate, well-supported work
- CPA or equivalent
- Life sciences, biotechnology, or pharmaceutical industry experience
- Public company experience
- NetSuite and/or SAP experience
- Exposure to SOX controls and audit support
What We Do
Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at ScholarRock.com and follow @ScholarRock and on LinkedIn. For additional information on our guidelines, please visit https://scholarrock.com/community-guidelines/ For more information on how Scholar Rock collects, uses, and shares personal information, please visit: https://scholarrock.com/privacy-policy
